Details for New Drug Application (NDA): 215571
✉ Email this page to a colleague
The generic ingredient in ALBUTEROL SULFATE is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.
Summary for 215571
Tradename: | ALBUTEROL SULFATE |
Applicant: | Lexenpharm |
Ingredient: | albuterol sulfate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 215571
Mechanism of Action | Adrenergic beta2-Agonists |
Suppliers and Packaging for NDA: 215571
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALBUTEROL SULFATE | albuterol sulfate | SOLUTION;INHALATION | 215571 | ANDA | Lexenpharm (Suzhou) Limited | 81075-229 | 81075-229-01 | 30 POUCH in 1 CARTON (81075-229-01) / 5 VIAL in 1 POUCH (81075-229-05) / 3 mL in 1 VIAL |
ALBUTEROL SULFATE | albuterol sulfate | SOLUTION;INHALATION | 215571 | ANDA | Lexenpharm (Suzhou) Limited | 81075-230 | 81075-230-01 | 30 POUCH in 1 CARTON (81075-230-01) / 5 VIAL in 1 POUCH (81075-230-05) / 3 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INHALATION | Strength | EQ 0.021% BASE | ||||
Approval Date: | May 3, 2024 | TE: | AN | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INHALATION | Strength | EQ 0.042% BASE | ||||
Approval Date: | May 3, 2024 | TE: | AN | RLD: | No |
Complete Access Available with Subscription